Skip to Content

Notice

Meeting of the Drug Control Research, Data, and Evaluation Advisory Committee

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Office of National Drug Control Policy.

ACTION:

Notice of Meeting.

SUMMARY:

The Drug Control Research, Data, and Evaluation Advisory Committee will meet to discuss federal drug control initiatives, ONDCP's three strategic priorities: Stopping Drug Use Before it Starts; Healing America's Drug Users; and Disrupting the Market, and the operational aspects of the: (1) Media Campaign; (2) 25 Cities Initiative; (3) Marijuana Initiative; (4) Domestic Market Disruption; (5) Student Drug Testing; (6) Prescription Drug Safety; (7) Colombia/Mexico; and (8) Access to Recovery.

DATES:

The meeting will be held Thursday, April 1, through Friday, April 2, 2004 each day from 9 a.m. to 4 p.m. There will be an opportunity for public comment on April 1st from 3:30 p.m. to 4 p.m.

ADDRESSES:

The meeting will be held at the Office of National Drug Control Policy, 750 17th Street, NW., 5th Floor Conference Room, Washington, DC.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Janie Dargan, (202) 395-6714.

Start Signature

Dated: February 27, 2004.

Daniel R. Petersen,

Assistant General Counsel.

End Signature End Further Info End Preamble

[FR Doc. 04-4687 Filed 3-2-04; 8:45 am]

BILLING CODE 3180-02-P